Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate Sponsor : Hoffmann-La Roche Not yet recruiting - verified July 2011

Condition : Knee Osteoarthritis Interventions : Biological: platelet-rich plasma; Drug: Corticosteroid Sponsors : Hospital Universitari Vall d'Hebron Research Institute; Hospital Universitari Vall d'H...

Condition : Psoriatic Arthritis Interventions : Drug: Tofacitinib (CP-690,550); Drug: Tofacitinib (CP-690,550); Drug: Placebo; Drug: Placebo Sponsor : Pfizer Not yet recruiting - verified August 2011

This open-label, retrospective, observational study will evaluate the compliance to RoActemra/Actemra (tocilizumab) therapy in patients with moderate to severe rheumatoid arthritis. Six months data wi...

This open-label, retrospective, observational study will evaluate the compliance to RoActemra/Actemra (tocilizumab) therapy in patients with moderate to severe rheumatoid arthritis. Six months data wi...

This open-label, retrospective, observational study will evaluate the compliance to RoActemra/Actemra (tocilizumab) therapy in patients with moderate to severe rheumatoid arthritis. Six months data wi...

This open-label, retrospective, observational study will evaluate the compliance to RoActemra/Actemra (tocilizumab) therapy in patients with moderate to severe rheumatoid arthritis. Six months data wi...

Condition : Rheumatoid Arthritis Interventions : Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: prednisone; Other: prednisone; Other: placebo Sponsor : Pfizer Recrui...

Condition : Rheumatoid Arthritis Interventions : Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: prednisone; Other: prednisone; Other: placebo Sponsor : Pfizer Recrui...

Condition : Rheumatoid Arthritis Interventions : Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: PF-04171327; Drug: prednisone; Other: prednisone; Other: placebo Sponsors : Pfizer; Pfiz...